{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:41:52Z","timestamp":1794494512687,"version":"4.9.1"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.euroneuro.2026.112863","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T19:36:29Z","timestamp":1779305789000},"page":"112863","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The American Society of Clinical Psychopharmacology task force consensus statement on the deprescribing of stimulant medications in adults with ADHD\u2730"],"prefix":"10.1016","volume":"111","author":[{"given":"David W.","family":"Goodman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajnish","family":"Mago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6098-9266","authenticated-orcid":false,"given":"Leslie","family":"Citrome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7611-9900","authenticated-orcid":false,"given":"Holly A.","family":"Swartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4733-2523","authenticated-orcid":false,"given":"Roger S.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlene P.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4372-0879","authenticated-orcid":false,"given":"Anita H.","family":"Clayton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siegfried","family":"Kasper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0548-0053","authenticated-orcid":false,"given":"Eduard","family":"Vieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur Robin","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Frye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Gitlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2207-0598","authenticated-orcid":false,"given":"Lawrence J.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph U.","family":"Correll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Gorwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2512-2835","authenticated-orcid":false,"given":"Dan V.","family":"Iosifescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish K.","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1662-7436","authenticated-orcid":false,"given":"Ralph","family":"Kupka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Macaluso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4524-9091","authenticated-orcid":false,"given":"Gin S.","family":"Malhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip B.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snehal","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Tohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew A.","family":"Nierenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Sajatovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Thase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Zohar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott T.","family":"Aaronson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel L.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph F.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2026.112863_bib0001","series-title":"Australian Evidence-Based Clinical Practice Guideline For Attention Deficit Hyperactivity Disorder (ADHD)","year":"2022"},{"key":"10.1016\/j.euroneuro.2026.112863_bib0002","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11920-006-0044-9","article-title":"Combination pharmacotherapy for adult ADHD","volume":"8","author":"Adler","year":"2006","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.euroneuro.2026.112863_bib0003","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/1087054712441969","article-title":"A 9-week, randomized, double-blind, placebo-controlled, parallel-group, dose-finding study to evaluate the efficacy and safety of modafinil as treatment for adults with ADHD","volume":"18","author":"Arnold","year":"2014","journal-title":"J. Atten. Disord."},{"key":"10.1016\/j.euroneuro.2026.112863_bib0004","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1176\/appi.ajp.2017.17070733","article-title":"Drug treatments for ADHD reduce risk of substance use disorders","volume":"174","author":"Asherson","year":"2017","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2026.112863_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2023.115449","article-title":"Prevalence of attention deficit hyperactivity disorder in adults: umbrella review of evidence generated across the globe","volume":"328","author":"Ayano","year":"2023","journal-title":"Psychiatry Res."},{"issue":"suppl 11","key":"10.1016\/j.euroneuro.2026.112863_bib0006","first-page":"3","article-title":"Pharmacotherapy for attention-deficit\/hyperactivity disorder (ADHD) decreases the risk for substance abuse: findings from a longitudinal follow-up of youths with and without ADHD","volume":"64","author":"Biederman","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2026.112863_bib0007","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/JCP.0b013e3181ee84a7","article-title":"A randomized, 3-phase, 34-week, double-blind, long-term efficacy study of osmotic-release oral system methylphenidate in adults with attention-deficit\/hyperactivity disorder","volume":"30","author":"Biederman","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2026.112863_bib0008","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1176\/appi.ajp.2007.07091486","article-title":"Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study","volume":"165","author":"Biederman","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2026.112863_bib0009","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jpsychires.2020.01.006","article-title":"A literature review and meta-analysis on the effects of ADHD medications on functional outcomes","volume":"123","author":"Boland","year":"2020","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.euroneuro.2026.112863_bib0010","doi-asserted-by":"crossref","first-page":"977","DOI":"10.4088\/JCP.11m07430","article-title":"Maintenance of efficacy of lisdexamfetamine dimesylate in adults with attention-deficit\/hyperactivity disorder: randomized withdrawal design","volume":"73","author":"Brams","year":"2012","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2026.112863_bib0011","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1111\/bph.13813","article-title":"Lifestyle use of drugs by healthy people for enhancing cognition, creativity, motivation and pleasure","volume":"174","author":"d\u2019Angelo","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2026.112863_bib0012","series-title":"Canadian ADHD Practice Guidelines","year":"2020"},{"key":"10.1016\/j.euroneuro.2026.112863_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101780","article-title":"Attention-deficit\/hyperactivity disorder medication consumption in 64 countries and regions from 2015 to 2019: a longitudinal study","volume":"58","author":"Chan","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.euroneuro.2026.112863_bib0014","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.biopsych.2019.04.009","article-title":"Risks and benefits of attention-deficit\/hyperactivity disorder medication on behavioral and neuropsychiatric outcomes: a qualitative review of pharmacoepidemiology studies using linked prescription databases","volume":"86","author":"Chang","year":"2019","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2026.112863_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2024.1508732","article-title":"Methylphenidate abuse and misuse in patients affected with a psychiatric disorder and a substance use disorder: a systematic review","volume":"15","author":"Chiappini","year":"2024","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.euroneuro.2026.112863_bib0016","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3810\/pgm.2014.09.2801","article-title":"The potential for misuse and abuse of medications in ADHD: a review","volume":"126","author":"Clemow","year":"2014","journal-title":"Postgrad. Med."},{"issue":"3","key":"10.1016\/j.euroneuro.2026.112863_bib0017","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/wps.21374","article-title":"Attention-deficit\/hyperactivity disorder (ADHD) in adults: evidence base, uncertainties and controversies","volume":"24","author":"Cortese","year":"2025","journal-title":"World Psych."},{"key":"10.1016\/j.euroneuro.2026.112863_bib0018","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000487767","article-title":"International consensus statement on screening, diagnosis and treatment of substance use disorder patients with comorbid attention deficit\/hyperactivity disorder","volume":"24","author":"Crunelle","year":"2018","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.euroneuro.2026.112863_bib0019","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/S0140-6736(14)61684-6","article-title":"Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: a nationwide cohort study","volume":"385","author":"Dalsgaard","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.euroneuro.2026.112863_bib0020","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2013.12.002","article-title":"Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies","volume":"67","author":"Diamond","year":"2014","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.euroneuro.2026.112863_bib0021","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1017\/neu.2021.23","article-title":"Children and adolescents with ADHD followed up to adulthood: a systematic review of long-term outcomes","volume":"33","author":"Di Lorenzo","year":"2021","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.euroneuro.2026.112863_bib0022","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2217\/npy.13.59","article-title":"Changes in the definition of ADHD in DSM-5: subtle but important","volume":"3","author":"Epstein","year":"2013","journal-title":"NeuroPsychiatry (London)"},{"key":"10.1016\/j.euroneuro.2026.112863_bib0023","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.neubiorev.2021.01.022","article-title":"The world federation of ADHD International consensus statement: 208 evidence-based conclusions about the disorder","volume":"128","author":"Faraone","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.euroneuro.2026.112863_bib0024","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1017\/S0033291707000335","article-title":"A naturalistic study of the effects of pharmacotherapy on substance use disorders among ADHD adults","volume":"37","author":"Faraone","year":"2007","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2026.112863_bib0025","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jaac.2019.06.012","article-title":"Systematic review: nonmedical use of prescription stimulants: risk factors, outcomes, and risk reduction strategies","volume":"59","author":"Faraone","year":"2020","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"suppl 11","key":"10.1016\/j.euroneuro.2026.112863_bib0026","first-page":"15","article-title":"Effect of stimulant medications for attention-deficit\/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion","volume":"68","author":"Faraone","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2026.112863_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2025.1612785","article-title":"Misuse and diversion of stimulant medications prescribed for the treatment of ADHD: a systematic review","volume":"16","author":"Forrest","year":"2025","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.euroneuro.2026.112863_bib0028","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jpsychires.2024.02.050","article-title":"The prevalence of cannabis use disorder in attention-deficit hyperactivity disorder: a clinical epidemiological meta-analysis","volume":"172","author":"Froude","year":"2024","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.euroneuro.2026.112863_bib0029","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.25ac15936","article-title":"What is meant by the term \u2018deprescribing,\u2019 and does it belong in our lexicon?","volume":"86","author":"Goldberg","year":"2025","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2026.112863_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euroneuro.2024.03.002","article-title":"Settling a distracted globe: an overview of psychosocial and psychotherapeutic treatment of attention-deficit\/hyperactivity disorder","volume":"83","author":"Gonda","year":"2024","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2026.112863_bib0031","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1017\/S1092852922000785","article-title":"Attentional problems occur across multiple psychiatric disorders and are not specific for ADHD","volume":"28","author":"Grant","year":"2023","journal-title":"CNS. Spectr."},{"key":"10.1016\/j.euroneuro.2026.112863_bib0032","article-title":"Exploring the link between attention-deficit hyperactivity disorder and cannabis use disorders: a review","volume":"29","author":"Gujska","year":"2023","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.euroneuro.2026.112863_bib0033","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.psc.2022.05.010","article-title":"Attention-deficit hyperactivity disorder and therapeutic cannabis use motives","volume":"45","author":"Hernandez","year":"2022","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.euroneuro.2026.112863_bib0034","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s12325-013-0085-5","article-title":"Methylphenidate hydrochloride modified-release in adults with attention deficit hyperactivity: a randomized double-blind placebo-controlled trial","volume":"31","author":"Huss","year":"2014","journal-title":"Adv. Ther."},{"key":"10.1016\/j.euroneuro.2026.112863_bib0035","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1177\/1087054714548035","article-title":"Drug holidays from ADHD medication: international experience over the past four decades","volume":"19","author":"Ibrahim","year":"2015","journal-title":"J. Atten. Disord."},{"key":"10.1016\/j.euroneuro.2026.112863_bib0036","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1162\/jocn_a_00776","article-title":"Prescription stimulants\u2019 effects on healthy inhibitory control, working memory, and episodic memory: a meta-analysis","volume":"27","author":"Ilieva","year":"2015","journal-title":"J. Cogn. Neurosci."},{"key":"10.1016\/j.euroneuro.2026.112863_bib0037","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3389\/fnins.2013.00198","article-title":"Enhancement stimulants: perceived motivational and cognitive advantages","volume":"7","author":"Ilieva","year":"2013","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.euroneuro.2026.112863_bib0038","unstructured":"IQVIA-Report-on-Stimulant-Trends-2024.Pdf. Accessed 28 July 2025. [Online]. Available: https:\/\/deadiversion.usdoj.gov\/pubs\/docs\/IQVIA-Report-on-Stimulant-Trends-2024.pdf."},{"key":"10.1016\/j.euroneuro.2026.112863_bib0039","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1177\/0269216317690685","article-title":"Guidance on conducting and REporting DElphi Studies (CREDES) in palliative care: recommendations based on a methodological systematic review","volume":"31","author":"J\u00fcnger","year":"2017","journal-title":"Palliat. Med."},{"key":"10.1016\/j.euroneuro.2026.112863_bib0040","doi-asserted-by":"crossref","first-page":"7529","DOI":"10.1016\/j.cell.2025.11.039","article-title":"Stimulant medications affect arousal and reward, not attention networks","volume":"188","author":"Kay","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.euroneuro.2026.112863_bib0041","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.5335","article-title":"Overdiagnosis of attention-deficit\/hyperactivity disorder in children and adolescents: a systematic scoping review","volume":"4","author":"Kazda","year":"2021","journal-title":"JAMa Netw. Open."},{"key":"10.1016\/j.euroneuro.2026.112863_bib0042","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0289009","article-title":"Disciplinary trends in the use of the Delphi method: a bibliometric analysis","volume":"18","author":"Khodyakov","year":"2023","journal-title":"PLoS. One"},{"key":"10.1016\/j.euroneuro.2026.112863_bib0043","author":"Khodyakov"},{"key":"10.1016\/j.euroneuro.2026.112863_bib0044","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.eurpsy.2018.11.001","article-title":"Updated European consensus statement on diagnosis and treatment of adult ADHD","volume":"56","author":"Kooij","year":"2019","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.euroneuro.2026.112863_bib0045","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1177\/10870547231158572","article-title":"Functional impairments associated with ADHD in adulthood and the impact of pharmacological treatment","volume":"27","author":"Kosheleff","year":"2023","journal-title":"J. Atten. Disord."},{"key":"10.1016\/j.euroneuro.2026.112863_bib0046","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1177\/07067437241245384","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 update on clinical guidelines for management of major depressive disorder in adults","volume":"69","author":"Lam","year":"2024","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2026.112863_bib0047","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.38088","article-title":"Adult attention-deficit\/hyperactivity disorder and the risk of dementia","volume":"6","author":"Levine","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.euroneuro.2026.112863_bib0048","first-page":"830","article-title":"Increased prescribing of ADHD medication and real-world outcomes over time","volume":"82","author":"Li","year":"2025","journal-title":"JAMA Psych."},{"issue":"2\u20133","key":"10.1016\/j.euroneuro.2026.112863_bib0049","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.schres.2013.03.019","article-title":"A systematic review of psychostimulant treatment of negative symptoms of schizophrenia: challenges and therapeutic opportunities","volume":"147","author":"Lindenmayer","year":"2013","journal-title":"Schizophr. Res."},{"issue":"5","key":"10.1016\/j.euroneuro.2026.112863_bib0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004390","article-title":"ACcurate COnsensus Reporting Document (ACCORD) explanation and elaboration: guidance and examples to support reporting consensus methods","volume":"21","author":"Logullo","year":"2024","journal-title":"PLoS. Med."},{"key":"10.1016\/j.euroneuro.2026.112863_bib0051","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.642798","article-title":"Intentional discontinuation of psychostimulants used to treat ADHD in youth: a review and analysis","volume":"12","author":"Lohr","year":"2021","journal-title":"Front. Psychiatry"},{"issue":"5","key":"10.1016\/j.euroneuro.2026.112863_bib0052","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S2215-0366(25)00045-8","article-title":"Does ADHD treatment inefficacy question its diagnostic validity?","volume":"12","author":"Malhi","year":"2025","journal-title":"Lancet Psych."},{"key":"10.1016\/j.euroneuro.2026.112863_bib0053","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1176\/appi.ajp.2008.07091465","article-title":"Age at methylphenidate treatment initiation in children with ADHD and later substance abuse: prospective follow-up into adulthood","volume":"165","author":"Mannuzza","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2026.112863_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2025.119427","article-title":"The changing prevalence of ADHD? A systematic review","volume":"388","author":"Martin","year":"2025","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2026.112863_bib0055","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1177\/00048674231166329","article-title":"The Australian evidence-based clinical practice guideline for attention deficit hyperactivity disorder","volume":"57","author":"May","year":"2023","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2026.112863_bib0056","doi-asserted-by":"crossref","first-page":"E2657","DOI":"10.1073\/pnas.1206820109","article-title":"Persistent cannabis users show neuropsychological decline from childhood to midlife","volume":"109","author":"Meier","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.euroneuro.2026.112863_bib0057","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/CHI.0b013e31819c23d0","article-title":"The MTA at 8 years: prospective follow-up of children treated for combined type ADHD in a multisite study","volume":"48","author":"Molina","year":"2009","journal-title":"J. Am. Acad. Child Adolesc. Psych."},{"key":"10.1016\/j.euroneuro.2026.112863_bib0058","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.mayocp.2022.02.026","article-title":"Attention-deficit\/hyperactivity disorder overdiagnosis and overprescriptions: medicalization of distractions","volume":"97","author":"Moustafa","year":"2022","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.euroneuro.2026.112863_bib0059","first-page":"1056","article-title":"Sex differences in the trajectories of attention-deficit\/hyperactivity disorder symptoms from childhood to adulthood: a population-representative longitudinal study","volume":"58","author":"Murray","year":"2019","journal-title":"J. Am. Acad. Child Adolesc. Psych."},{"key":"10.1016\/j.euroneuro.2026.112863_bib0060","series-title":"NICE Guideline [NG87]","article-title":"Attention deficit hyperactivity disorder: diagnosis and management","year":"2019"},{"key":"10.1016\/j.euroneuro.2026.112863_bib0061","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E","article-title":"Two-sided confidence intervals for the single proportion: comparison of seven methods","volume":"17","author":"Newcombe","year":"1998","journal-title":"Stat. Med."},{"key":"10.1016\/j.euroneuro.2026.112863_bib0062","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1192\/bjp.2024.199","article-title":"Life expectancy and years of life lost for adults with diagnosed ADHD in the UK: matched cohort study","volume":"226","author":"O'Nions","year":"2025","journal-title":"Br. J. Psych."},{"key":"10.1016\/j.euroneuro.2026.112863_bib0063","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/ije\/dyt261","article-title":"ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis","volume":"43","author":"Polanczyk","year":"2014","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.euroneuro.2026.112863_bib0064","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1176\/appi.ajp.2017.16060686","article-title":"ADHD medication and substance-related problems","volume":"174","author":"Quinn","year":"2017","journal-title":"Am. J. Psych."},{"key":"10.1016\/j.euroneuro.2026.112863_bib0065","doi-asserted-by":"crossref","DOI":"10.1111\/eip.70123","article-title":"Neurodevelopmental, pharmacological and substance use factors in the association between ADHD and first-episode non-affective psychosis: a systematic review","volume":"20","author":"Ricci","year":"2026","journal-title":"Early. Interv. Psych."},{"key":"10.1016\/j.euroneuro.2026.112863_bib0066","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3390\/brainsci12081004","article-title":"Malingering and stimulant medications abuse, misuse and diversion","volume":"12","author":"Sadek","year":"2022","journal-title":"Brain Sci."},{"key":"10.1016\/j.euroneuro.2026.112863_bib0067","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1176\/appi.ajp.2021.21010032","article-title":"Variable patterns of remission from ADHD in the multimodal treatment study of ADHD","volume":"179","author":"Sibley","year":"2022","journal-title":"Am. J. Psych."},{"key":"10.1016\/j.euroneuro.2026.112863_bib0068","first-page":"1","article-title":"ADHD: real-world consequences of missed diagnosis and mistreatment","volume":"Feb 23","author":"Szymaniak","year":"2026","journal-title":"Br. J. Psych."},{"key":"10.1016\/j.euroneuro.2026.112863_bib0069","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.30795","article-title":"Assessment of stimulant use and cardiovascular event risks among older adults","volume":"4","author":"Tadrous","year":"2021","journal-title":"JAMa Netw. Open."},{"key":"10.1016\/j.euroneuro.2026.112863_bib0070","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.aap.2013.10.003","article-title":"ADHD and relative risk of accidents in road traffic: a meta-analysis","volume":"62","author":"Vaa","year":"2014","journal-title":"Accid. Anal. Prev."},{"issue":"suppl 1","key":"10.1016\/j.euroneuro.2026.112863_bib0071","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.drugalcdep.2011.12.018","article-title":"Common liability to addiction and \u201cgateway hypothesis\u201d: theoretical, empirical and evolutionary perspective","volume":"123","author":"Vanyukov","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.euroneuro.2026.112863_bib0072","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1177\/10870547231218450","article-title":"ADHD in adults: does age at diagnosis matter?","volume":"28","author":"Vater","year":"2024","journal-title":"J. Atten. Disord."},{"key":"10.1016\/j.euroneuro.2026.112863_bib0073","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/chi.0b013e31815a56f1","article-title":"Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature","volume":"47","author":"Wilens","year":"2008","journal-title":"J. Am. Acad. Child Adolesc. Psych."},{"key":"10.1016\/j.euroneuro.2026.112863_bib0074","doi-asserted-by":"crossref","first-page":"940","DOI":"10.4088\/JCP.14m09559","article-title":"Nonmedical stimulant use in college students: association with attention-deficit\/hyperactivity disorder and other disorders","volume":"77","author":"Wilens","year":"2016","journal-title":"J. Clin. Psych."},{"key":"10.1016\/j.euroneuro.2026.112863_bib0075","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.1471","article-title":"Twenty-year trends in diagnosed attention-deficit\/hyperactivity disorder among US children and adolescents, 1997-2016","volume":"1","author":"Xu","year":"2018","journal-title":"JAMa Netw. Open."},{"key":"10.1016\/j.euroneuro.2026.112863_bib0076","doi-asserted-by":"crossref","first-page":"84","DOI":"10.5498\/wjp.v13.i3.84","article-title":"Identification and treatment of individuals with attention-deficit\/hyperactivity disorder and substance use disorder: an expert consensus statement","volume":"13","author":"Young","year":"2023","journal-title":"World J. Psych."},{"key":"10.1016\/j.euroneuro.2026.112863_bib0077","first-page":"178","article-title":"Attention-deficit\/hyperactivity disorder medications and long-term risk of cardiovascular diseases","volume":"81","author":"Zhang","year":"2024","journal-title":"JAMa Psych."},{"key":"10.1016\/j.euroneuro.2026.112863_bib0078","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1016\/j.euroneuro.2015.08.019","article-title":"A review of the current nomenclature for psychotropic agents and an introduction to the neuroscience-based nomenclature","volume":"25","author":"Zohar","year":"2015","journal-title":"Eur. Neuropsychopharmacol."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X26001045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X26001045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T12:15:30Z","timestamp":1786536930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X26001045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":78,"alternative-id":["S0924977X26001045"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2026.112863","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The American Society of Clinical Psychopharmacology task force consensus statement on the deprescribing of stimulant medications in adults with ADHD\u2730","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2026.112863","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. and ECNP. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112863"}}